Company intelligence / Profile preview

Impact NRS

New York, New York, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Impact NRS is a multidisciplinary platform innovation company that spins out and commercializes technologies in areas such as agri-biotech, functional genomics, molecular diagnostics in oncology, and animal health. Clinical results are not directly published as the company focuses on developing and enabling portfolio companies rather than its own therapeutics pipeline[2][4].

Therapeutic areas: GastroenterologyOncologyOther
Modalities: Gene-editingData scienceMicrobiomeOncology diagnosticsSynthetic biologySmall moleculeBiologic
Industry: Molecular Diagnostics

Partnerships

National Institute for Biotechnology in the Negev (NIBN)Agricultural Research Organization (Volcani Center, Israel)Yeda (Weizmann Institute of Science commercial arm)

Beyond the preview

Go deeper on Impact NRS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impact NRS.

Explore the full profile